102 related articles for article (PubMed ID: 16187969)
21. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
22. [Eradication of Helicobacter pylori and hemorrhagic recurrence of duodenal ulcer].
Gisbert JP; Boixeda D; Hernández Ranz F; Martín de Argila C
Rev Esp Enferm Dig; 1995 Dec; 87(12):910-1. PubMed ID: 8562204
[No Abstract] [Full Text] [Related]
23. Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori.
Graham DY; Opekun AR; Belson G; El-Zimaity HM; Carlson MR
Aliment Pharmacol Ther; 2005 Jan; 21(2):165-8. PubMed ID: 15679766
[TBL] [Abstract][Full Text] [Related]
24. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
[TBL] [Abstract][Full Text] [Related]
25. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
[TBL] [Abstract][Full Text] [Related]
26. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
Guivarc'h PH; Vachon MG; Fordyce D
Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
[TBL] [Abstract][Full Text] [Related]
27. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
[TBL] [Abstract][Full Text] [Related]
28. A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule.
de Boer WA; van Etten RJ; Schneeberger PM; Tytgat GN
Am J Gastroenterol; 2000 Mar; 95(3):641-5. PubMed ID: 10710051
[TBL] [Abstract][Full Text] [Related]
29. Randomized comparison of two rescue therapies for Helicobacter pylori infection.
Wu DC; Hsu PI; Chen A; Lai KH; Tsay FW; Wu CJ; Lo GH; Wu JY; Wu IC; Wang WM; Tseng HH
Eur J Clin Invest; 2006 Nov; 36(11):803-9. PubMed ID: 17032348
[TBL] [Abstract][Full Text] [Related]
30. Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
Graham DY; Belson G; Abudayyeh S; Osato MS; Dore MP; El-Zimaity HM
Dig Liver Dis; 2004 Jun; 36(6):384-7. PubMed ID: 15248377
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy.
Lee SK; Lee SW; Park JY; Kwon BS; Kim SY; Hyun JJ; Kim JH; Jung SW; Koo JS; Yim HJ; Choi JH
Helicobacter; 2011 Oct; 16(5):410-4. PubMed ID: 21923688
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
33. Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies.
Kate V; Ananthakrishnan N; Badrinath S
Br J Surg; 2001 Aug; 88(8):1054-8. PubMed ID: 11488789
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori eradication: A new, single-capsule bismuth-containing quadruple therapy.
Gisbert JP
Nat Rev Gastroenterol Hepatol; 2011 Jun; 8(6):307-9. PubMed ID: 21643037
[No Abstract] [Full Text] [Related]
35. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
[TBL] [Abstract][Full Text] [Related]
36. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
37. [Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
Gisbert JP; Boixeda D; Vila T; de Rafael L; Alvarez Baleriola I; Martín de Argila C
Med Clin (Barc); 1995 Nov; 105(15):561-5. PubMed ID: 7500674
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects.
Jeon JY; Kim SY; Moon SJ; Oh K; Lee J; Kim B; Song GS; Kim MG
Clin Ther; 2021 Apr; 43(4):722-734. PubMed ID: 33637332
[TBL] [Abstract][Full Text] [Related]
39. Influence of omeprazole on bioavailability of bismuth following administration of a triple capsule of bismuth biskalcitrate, metronidazole, and tetracycline.
Spénard J; Aumais C; Massicotte J; Tremblay C; Lefebvre M
J Clin Pharmacol; 2004 Jun; 44(6):640-5. PubMed ID: 15145972
[TBL] [Abstract][Full Text] [Related]
40. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]